rxstat › Drug prices › Linagliptin

Linagliptin (Trajenta) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Linagliptin 5 mg tablet costs about $2.35 to $2.81 per tablet on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee.

Linagliptin has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formABSKONNBNS
5 mg Tabletper tablet$2.74$2.74$2.81$2.35$2.43
Plan coverageCoveredSpecial approvalCoveredCoveredSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 1 product
  • Trajenta 5 mg Tablet · BOE
    DIN 02370921 · $2.74/tablet · Covered
Saskatchewan: 1 product
  • Trajenta 5 mg Tablet · BOE
    DIN 02370921 · $2.74/tablet · Special approval
Ontario: 1 product
  • Trajenta 5 mg Tablet · Boehringer-Ingelheim (Canada) Ltd./Ltee
    DIN 02370921 · $2.81/tablet · Covered
New Brunswick: 1 product
  • Trajenta 5 mg Tablet · BOE
    DIN 02370921 · $2.35/tablet · Covered
Nova Scotia: 1 product
  • Trajenta 5 mg Tablet · BOE
    DIN 02370921 · $2.43/tablet · Special approval

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
3

Reports by product

The DIN is printed on your prescription label.

Avoided
TRAJENTA
5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02370921 · ended Apr 4, 2020 · Delay in shipping of the drug.
Resolved
TRAJENTA
5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02370921 · ended Dec 21, 2017 · Disruption of the manufacture of the drug.
Resolved
TRAJENTA
5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02370921 · ended Jul 31, 2017 · Disruption of the manufacture of the drug.

What's happening

There are no active shortage reports for Linagliptin. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Linagliptin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BH).

Recent changes

Common questions

How much does Linagliptin cost in Canada?

Linagliptin 5 mg tablet costs about $2.35 to $2.81 per tablet on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee.

Is Linagliptin covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: covered; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Linagliptin be back in stock in Canada?

Linagliptin has no active shortage; supply is normal per Health Canada reports.

Why is Linagliptin in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (blood glucose lowering drugs, excl. insulins)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.